Targovax ASA: third quarter 2020 results ...Middle East

News by : (PR Newswire) -
OSLO, Norway, Nov. 5, 2020 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its third quarter 2020 results. An online presentation by Targovax's management to investors,...

Read More Details
Finally We wish PressBee provided you with enough information of ( Targovax ASA: third quarter 2020 results )

Also on site :

Most Viewed News
جديد الاخبار